Katarina Starčević

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Antiplatelet Therapy

Chronic Kidney Disease

Polycyclic Aromatic Hydrocarbons

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Ivana Karmelić, Ivana Rubić, Katarina Starčević, David Ozretić, Zdravka Poljaković, Mia Jurilj Sajko, Vladimir Kalousek, Rafaela Kalanj, Dina Rešetar Maslov, Josipa Kuleš, Marina Roje Bedeković, Tomislav Sajko, Krešimir Rotim, Vladimir Mrljak, Dragana Fabris
Comparative Targeted Metabolomics of Ischemic Stroke: Thrombi and Serum Profiling for the Identification of Stroke-Related Metabolites. Biomedicines 12 (8) (2024)
Ivana Karmelić, Ivana Rubić, Katarina Starčević, David Ozretić, Zdravka Poljaković, Mia Jurilj Sajko, Vladimir Kalousek, Rafaela Kalanj, Dina Rešetar Maslov, Josipa Kuleš, Marina Roje Bedeković, Tomislav Sajko, Krešimir Rotim, Vladimir Mrljak, Dragana Fabris
Comparative Targeted Metabolomics of Ischemic Stroke: Thrombi and Serum Profiling for the Identification of Stroke-Related Metabolites. Biomedicines 12 (8) (2024)
Lana Ganoci, Jozefina Palić, Vladimir Trkulja, Katarina Starčević, Livija Šimičević, Nada Božina, Martina Lovrić-Benčić, Zdravka Poljaković, Tamara Božina
Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients? Genes 15 (5) (2024)
Lana Ganoci, Jozefina Palić, Vladimir Trkulja, Katarina Starčević, Livija Šimičević, Nada Božina, Martina Lovrić-Benčić, Zdravka Poljaković, Tamara Božina
Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients? Genes 15 (5) (2024)
Lana Ganoci, Jozefina Palić, Vladimir Trkulja, Katarina Starčević, Livija Šimičević, Nada Božina, Martina Lovrić-Benčić, Zdravka Poljaković, Tamara Božina
Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients? Genes 15 (5) (2024)
Lana Ganoci, Jozefina Palić, Vladimir Trkulja, Katarina Starčević, Livija Šimičević, Nada Božina, Martina Lovrić-Benčić, Zdravka Poljaković, Tamara Božina
Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients? Genes 15 (5) (2024)